Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: A prospective randomized trial of intravenous compared with intraventricular vancomycin therapy

Journal of Neurosurgery

Volumn 98, Issue 5, 2003, Pages 1040-1044

  Pfausler, Bettina ^a   Spiss, Heinrich ^a   Beer, Ronny ^a   Kampfl, Andreas ^a   Engelhardt, Klaus ^a   Schober, Maria ^a   Schmutzhard, Erich ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Intraventricular vancomycin; Ventriculitis

Indexed keywords

VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BRAIN HEMORRHAGE; BRAIN VENTRICULITIS; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID CULTURE; CEREBROSPINAL FLUID DRAINAGE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRAIN; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG PENETRATION; FEMALE; HUMAN; IMPLANTATION; LABORATORY TEST; MALE; NONHUMAN; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION;

EID: 0037405183     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2003.98.5.1040     Document Type: Article

References (24)

1. Ahmed A, Jafri H, Lutsar I, et al: Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 43:876-881, 1999
2. Albanese J, Leone M, Bruguerolle B, et al: Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit. Antimicrob Agents Chemother 44: 1356-1358, 2000
3. Arroyo JC, Quindlen EA: Accumulation of vancomycin after intraventricular infusions. South Med J 76:1554-1555, 1983
4. Bayston R: CSF vancomycin concentrations. J Antimicrob Chemother 22:265-266, 1988 (Letter)
5. Bayston R: Epidemiology, diagnosis, treatment, and prevention of cerebrospinal fluid shunt infections. Neurosurg Clin N Am 12: 703-708, 2001
6. Bayston R, Hart CA, Barnicoat M: Intraventricular vancomycin in the treatment of ventriculitis associated with cerebrospinal fluid shunting and drainage. J Neurol Neurosurg Psychiatry 50: 1419-1423, 1987
7. Forward KR, Fewer HD, Stiver HG: Cerebrospinal fluid shunt infections. A review of 35 infections in 32 patients. J Neurosurg 59:389-394, 1983
8. Gump DW: Vancomycin for treatment of bacterial meningitis. Rev Infect Dis 3 (Suppl):S289-S292, 1981
9. Hawley HB, Gump DW: Vancomycin therapy of bacterial meningitis. Am J Dis Child 126:261-264, 1973
10. Hieber JP, Nelson JD: A pharmacologic evaluation of penicillin in children with purulent meningitis. N Engl J Med 297:410-413, 1977
11. Hirsch BE, Amodio M, Einzig AI, et al: Instillation of vancomycin into a cerebrospinal fluid reservoir to clear infection: pharmacokinetic considerations. J Infect Dis 163:197-200, 1991
12. Jacobs F, Deleluse F, Raftopoulos C, et al: Intraventricular vancomycin in CSF shunt infections. Neurosurgery 21:112-113, 1987
13. Luer MS, Hatton J: Vancomycin administration into the cerebrospinal fluid: a review. Ann Pharmacother 27:912-921, 1993
14. Matzke GR, Zhanel GG, Guay DR: Clinical pharmacokinetics of vancomycin. Clin Pharmacokinet 11:257-282, 1986
15. Moellering RC Jr: Pharmacokinetics of vancomycin. J Antimicrob Chemother 14 (Suppl D):43-52, 1984
16. Moellering RC Jr, Krogstad DJ: Pharmacokinetics of vancomycin in normal subjects and in patients with reduced renal function. Rev Infect Dis 3 (Suppl):S230-S235, 1981
17. Pfausler B, Haring HP, Kampfl A, et al: Cerebrospinal fluid (CSF) pharmacokinetics of intraventricular vancomycin in patients with staphylococcal ventriculitis associated with external CSF drainage. Clin Infect Dis 25:733-735, 1997
18. Redfield DC, Underman A, Norman D, et al: Cerebrospinal fluid penetration of vancomycin, in bacterial meningitis, in Nelson JD, Grassi C (eds): Current Chemotherapy and Infectious Disease. Proceedings of the 11th International Congress of Chemotherapy and 19th Interscience Conference on Antimicriobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1980, Vol 1, pp 638-640
19. Roos KL, Scheld WM: The management of fulminant meningitis in the intensive care unit. Crit Care Clin 4:375-392, 1988
20. Schaad UB, McCracken GH Jr, Nelson JD: Clinical pharmacology and efficacy of vancomycin in pediatric patients. J Pediatr 96: 119-126, 1980
21. Scheld WM: Drug delivery to the central nervous system: general principles and relevance to therapy for infections of the central nervous system. Rev Infect Dis (Suppl 7):S1669-S1690, 1989
22. Swayne R, Rampling A, Newsom SW: Intraventricular vancomycin for treatment of shunt-associated ventriculitis. J Antimicrob Chemother 19:249-253, 1987
23. Visconti EB, Peter G: Vancomycin treatment of cerebrospinal fluid shunt infections. Report of two cases. J Neurosurg 51: 245-246, 1979
24. Wald SL, McLaurin RL: Cerebrospinal fluid antibiotic levels during treatment of shunt infections. J Neurosurg 52:41-46, 1980